Other
MRD
MRD is an intervention with 5 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
3(60%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
5
all time
Status Distribution
Active(3)
Completed(2)
Detailed Status
Active, not recruiting3
Completed2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
3
Success Rate
100.0%
Trials by Status
active_not_recruiting360%
completed240%
Recent Activity
3 active trials
Showing 5 of 5
active_not_recruiting
A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC
NCT06443684
completed
MRD Detection by NGS in Pediatric T-ALL
NCT06525116
active_not_recruiting
CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer
NCT05210283
active_not_recruiting
First CORRECT Study of Minimal Residual Disease (MRD) Detection in Colorectal Cancer
NCT06398743
completed
MRD Detection by NGS in Pediatric B-ALL
NCT05973032
Clinical Trials (5)
Showing 5 of 5 trials
NCT06443684
A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC
NCT06525116
MRD Detection by NGS in Pediatric T-ALL
NCT05210283
CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer
NCT06398743
First CORRECT Study of Minimal Residual Disease (MRD) Detection in Colorectal Cancer
NCT05973032
MRD Detection by NGS in Pediatric B-ALL
All 5 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 5